Cetera Advisors LLC Bio Techne Corp Transaction History

Cetera Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $375,558 - $438,796	5,692 New	5,692 $400,000
Q1 2022 May 12, 2022	SELL	$353.85 - $487.79 $165,955 - $228,773	-469 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $93,510 - $107,637	-205 Reduced 30.42%	469 $243,000
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $212,053 - $277,014	674 New	674 $257,000

604

152M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.95B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.